A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results

BMC Medical Informatics and Decision Making

Volumn 13, Issue 1, 2013, Pages

  Zeliadt, Steven B ^a,b   Hannon, Peggy A ^b   Trivedi, Ranak B ^a,b   Bonner, Laura M ^a   Vu, Thuy T ^b   Simons, Carol ^a   Kimmie, Crystal A ^c,e   Hu, Elaine Y ^a   Zipperer, Chris ^d   Lin, Daniel W ^e,f  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Seattle Institute for Biomedical and Clinical Research   (United States)

^d WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Decision aid; Prostate biopsy; Prostate cancer; Treatment decision making

Indexed keywords

ADAPTIVE BEHAVIOR; AGED; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOCTOR PATIENT RELATION; FEASIBILITY STUDY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADAPTATION, PSYCHOLOGICAL; AGED; DECISION MAKING; FEASIBILITY STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 84873264888     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-13-19     Document Type: Article

References (29)

1. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL, Ann Intern Med 2008 148 6 435 448 18252677 (Pubitemid 351665443)
2. Quality of life and satisfaction with outcome among prostate-cancer survivors. Sanda MG, Dunn RL, Michalski J, N Engl J Med 2008 358 12 1250 1261 10.1056/NEJMoa074311 18354103 (Pubitemid 351439226)
3. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL, Davis WW, Hoffman RM, J Natl Cancer Inst 2004 96 18 1358 1367 10.1093/jnci/djh259 15367568 (Pubitemid 39406169)
4. Decision aids for people facing health treatment or screening decisions. OConnor AM, Bennett CL, Stacey D, Cochrane Database Syst Rev 2009 3 D001431 19588325
5. Patient decision aids for prostate cancer treatment: a systematic review of the literature. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA, CA Cancer J Clin 2009 59 6 379 390 10.3322/caac.20039 19841280
6. Empowerment of men newly diagnosed with prostate cancer. Davison BJ, Degner LF, Cancer Nurs 1997 20 3 187 196 10.1097/00002820-199706000-00004 9190093 (Pubitemid 27247287)
7. Offering a treatment choice in the irradiation of prostate cancer leads to better informed and more active patients, without harm to well-being. Van Tol-Geerdink JJ, Leer JW, van Lin EN, Int J Radiat Oncol Biol Phys 2008 70 2 442 448 10.1016/j.ijrobp.2007.06.058 17765404
8. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Davison BJ, Goldenberg SL, Wiens KP, Gleave ME, Cancer Nurs 2007 30 5 7 E15 10.1097/01.NCC.0000290819.22195.d6 17876177 (Pubitemid 47417672)
9. American Cancer Society guideline for the early detection of prostate cancer: update 201. Wolf AM, Wender RC, Etzioni RB, CA Cancer J Clin 2010 60 2 70 98 10.3322/caac.20066 20200110
10. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Zeliadt SB, Ramsey SD, Penson DF, Cancer 2006 106 9 1865 1874 10.1002/cncr.21822 16568450 (Pubitemid 43673200)
11. The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Denberg TD, Kim FJ, Flanigan RC, Med Care 2006 44 12 1137 1141 10.1097/01.mlr.0000233684.27657.36 17122719 (Pubitemid 44808676)
12. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Zeliadt SB, Moinpour CM, Blough DK, Am J Manag Care 2010 16 5 121 e130 20455638
13. Access to information sources and treatment considerations among men with local stage prostate cancer. Ramsey SD, Zeliadt SB, Arora NK, Urology 2009 74 3 509 515 10.1016/j.urology.2009.01.090 19589564
14. What is a pilot or feasibility study? A review of current practice and editorial policy. Arain M, Campbell MJ, Cooper CL, Lancaster GA, BMC Med Res Methodol 2010 10 67 10.1186/1471-2288-10-67 20637084
15. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Davis TC, Long SW, Jackson RH, Fam Med 1993 25 6 391 395 8349060 (Pubitemid 23183311)
16. Making the choice: deciding what to Do about early stage prostate cancer. Fagerlin A, Holmes-Rovner M, Rovner D, Wei JT, Ohene-Frempong JSS, Michigan Cancer Consortium http://www.prostatecancerdecision.org
17. Measuring patient knowledge of the risks and benefits of prostate cancer screening. Radosevich DM, Partin MR, Nugent S, Patient Educ Couns 2004 54 2 143 152 10.1016/S0738-3991(03)00207-6 15288907 (Pubitemid 39044525)
18. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Roth AJ, Rosenfeld B, Kornblith AB, Cancer 2003 97 11 2910 2918 10.1002/cncr.11386 12767107 (Pubitemid 36605162)
19. The PHQ-8 as a measure of current depression in the general population. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH, J Affect Disord 2009 114 1-3 163 173 18752852
20. Measuring depressive symptoms in heart failure: validity and reliability of the patient health questionnaire-8. Pressler SJ, Subramanian U, Perkins SM, Am J Crit Care 2011 20 2 146 152 10.4037/ajcc2010931 20378777
21. Interpersonal processes of care survey: patient-reported measures for diverse groups. Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J, Health Serv Res 2007 42 3 Pt 1 1235 1256 17489912 (Pubitemid 46699467)
22. The control preferences scale. Degner LF, Sloan JA, Venkatesh P, Can J Nurs Res 1997 29 3 21 43 9505581 (Pubitemid 127473357)
23. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW, J Natl Cancer Ins 2011 103 6 520 523 10.1093/jnci/djr007
24. Physicians decision-making style and psychosocial outcomes among cancer survivors. Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL, Patient Educ Couns 2009 77 3 404 412 10.1016/j.pec.2009.10.004 19892508
25. Perceived helpfulness of physicians communication behavior and breast cancer patients level of trust over time. Arora NK, Gustafson DH, J Gen Intern Med 2009 24 2 252 255 10.1007/s11606-008-0880-x 19089501
26. Are cancer-related decision aids effective? A systematic review and meta-analysis. OBrien MA, Whelan TJ, Villasis-Keever M, J Clin Oncol 2009 27 6 974 985 10.1200/JCO.2007.16.0101 19124808
27. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. Mcnaughton-Collins M, Walker-Corkery E, Barry MJ, J Natl Cancer Inst Monogr 2004 33 78 101 15504921
28. Decision making as coping. Luce MF, Health Psychol 2005 24 Suppl 4 23 S28 16045414
29. Getting down to details in the design and use of decision aids. Fagerlin A, Med Decis Making 2009 29 4 409 411 10.1177/0272989X09341794 19633270